POKClass II
Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
21 CFR 892.2060 / Radiology
POK is the FDA product code for Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer, a class II device type, regulated under 21 CFR 892.2060. FDA's definition for this code reads: "Assist users in characterizing lesions identified on acquired medical images". As of , FDA records hold 23 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- POK
- Device name
- Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer
- FDA definition
- Assist users in characterizing lesions identified on acquired medical images
- Regulation
- 21 CFR 892.2060
- Device class
- Class II
- Review panel
- Radiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 23
- Ingested recalls
- 0
Clearances, product code POK
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 4 |
Applicants with the most clearances
Product code POK| Applicant | Clearances |
|---|---|
| Koios Medical, Inc. | 4 |
| Brightheart | 3 |
| Brainomix Limited | 2 |
| Ischemaview, Inc. | 2 |
| Sonio | 2 |
| Aisap | 1 |
| Avenda Health Inc. | 1 |
| Avicenna.ai | 1 |
| Circle Cardiovascular Imaging Inc | 1 |
| Echo IQ, Ltd. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
